291 related articles for article (PubMed ID: 32297448)
1. Subtype-Guided
Wu S; Wang Y; Li J; Zhang N; Mo M; Klimberg S; Kaklamani V; Cochet A; Shao Z; Cheng J; Liu G
Oncologist; 2020 Apr; 25(4):e626-e633. PubMed ID: 32297448
[TBL] [Abstract][Full Text] [Related]
2. (18)F-FDG PET/CT with Contrast Enhancement for Evaluation of Axillary Lymph Node Involvement in T1 Breast Cancer.
Kong EJ; Chun KA; Cho IH; Lee SJ
Nucl Med Mol Imaging; 2010 Sep; 44(3):170-6. PubMed ID: 24899946
[TBL] [Abstract][Full Text] [Related]
3. Optimal [
Gebhart G; Keyaerts M; Guiot T; Flamen P; Ruiz-Borrego M; Stradella A; Bermejo B; Escriva-de-Romani S; Calvo Martínez L; Ribelles N; Fernandez-Abad M; Albacar C; Colleoni M; Garrigos L; Atienza de Frutos M; Dalenc F; Prat A; Marmé F; Schmid P; Kerrou K; Braga S; Gener P; Sampayo-Cordero M; Cortés J; Pérez-García JM; Llombart-Cussac A
J Nucl Med; 2024 May; 65(5):708-713. PubMed ID: 38575192
[TBL] [Abstract][Full Text] [Related]
4. Semiquantitative analysis of maximum standardized uptake values of regional lymph nodes in inflammatory breast cancer: is there a reliable threshold for differentiating benign from malignant?
Carkaci S; Adrada BE; Rohren E; Wei W; Quraishi MA; Mawlawi O; Buchholz TA; Yang W
Acad Radiol; 2012 May; 19(5):535-41. PubMed ID: 22300741
[TBL] [Abstract][Full Text] [Related]
5. Multimodal prediction of neoadjuvant treatment outcome by serial FDG PET and MRI in women with locally advanced breast cancer.
Kazerouni AS; Peterson LM; Jenkins I; Novakova-Jiresova A; Linden HM; Gralow JR; Hockenbery DM; Mankoff DA; Porter PL; Partridge SC; Specht JM
Breast Cancer Res; 2023 Nov; 25(1):138. PubMed ID: 37946201
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of CT and
Li H; Li L; Liu Y; Deng Y; Zhu Y; Huang L; Long T; Zeng L; Shu Y; Peng D
BMC Cancer; 2024 Apr; 24(1):434. PubMed ID: 38589832
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of blood supply and metabolism in tumor, axillary lymph node and normal breast tissue with F-18 FDG PET/CT in breast cancer: comparison with pathological prognostic factors.
Abdulrezzak U; Akgun H; Tutus A; Kula M; Dogan S; Oz AB; Ok E
BMC Womens Health; 2024 Jan; 24(1):45. PubMed ID: 38229093
[TBL] [Abstract][Full Text] [Related]
8. Comparing fluorodeoxyglucose positron emission tomography with computed tomography in staging for nodal and distant metastasis in urothelial/bladder cancer.
Al-Zubaidi M; Ong K; Viswambaram P; Bangash H; Boardman G; McCombie SP; Oey O; Swarbrick N; Redfern A; Ong J; Gauci R; Low R; Hayne D
BJUI Compass; 2024 Apr; 5(4):473-479. PubMed ID: 38633828
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers from in vivo molecular imaging of breast cancer: pretreatment
Gallivanone F; Panzeri MM; Canevari C; Losio C; Gianolli L; De Cobelli F; Castiglioni I
MAGMA; 2017 Aug; 30(4):359-373. PubMed ID: 28246950
[TBL] [Abstract][Full Text] [Related]
10.
Makhlin I; Korhonen KE; Martin ML; Gillman J; Schubert E; Pantel AR; Mankoff DA; Clark AS
Radiol Imaging Cancer; 2022 Nov; 4(6):e220032. PubMed ID: 36269154
[TBL] [Abstract][Full Text] [Related]
11. Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients.
Longoni M; Scilipoti P; Re C; Rosiello G; Nocera L; Pellegrino F; Basile G; de Angelis M; Quarta L; Burgio G; Necchi A; Cigliola A; Chiti A; Picchio M; Salonia A; Briganti A; Montorsi F; Moschini M
BJU Int; 2024 Apr; ():. PubMed ID: 38621771
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment
Gong C; Ma G; Hu X; Zhang Y; Wang Z; Zhang J; Zhao Y; Li Y; Xie Y; Yang Z; Wang B
Oncologist; 2018 Oct; 23(10):1144-1152. PubMed ID: 30082489
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of
Feng L; Yang S; Lin Y; Li J; Cao Z; Zheng Q; Wang H; Yang J
Pediatr Radiol; 2024 May; 54(6):954-964. PubMed ID: 38613691
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and accuracy of targeted axillary dissection in breast cancer patients; single center experience.
Kaya C; Burcu B; Çetinoğlu I; Uçak R; Çerekçi E; Şahin C; Demircioğlu ZG; Şener A; Halil S
Front Surg; 2023; 10():1332142. PubMed ID: 38269392
[TBL] [Abstract][Full Text] [Related]
15. Examination of iatrogenic FDG accumulation after COVID-19 vaccination.
Takahashi K; Manabe O; Shizukuishi K; Shibata H; Kawakami H; Otsuka A; Oyama-Manabe N
Ann Nucl Med; 2024 Jun; 38(6):409-417. PubMed ID: 38563890
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and molecular predictors of [
Llombart-Cussac A; Prat A; Pérez-García JM; Mateos J; Pascual T; Escrivà-de-Romani S; Stradella A; Ruiz-Borrego M; de Las Heras BB; Keyaerts M; Galvan P; Brasó-Maristany F; García-Mosquera JJ; Guiot T; Gion M; Sampayo-Cordero M; Di Cosimo S; Pérez-Escuredo J; de Frutos MA; Cortés J; Gebhart G
Eur J Nucl Med Mol Imaging; 2024 Apr; ():. PubMed ID: 38587643
[TBL] [Abstract][Full Text] [Related]
17. Detection of HER2 expression using
Zhao L; Xing Y; Liu C; Ma S; Huang W; Cheng Z; Zhao J
Breast Cancer Res; 2024 Mar; 26(1):40. PubMed ID: 38459598
[TBL] [Abstract][Full Text] [Related]
18. Value of
Zhang J; Jin F; Li C; Jiang W; Liu C; Zeng L; Jiang Y; Xu A; Fang N; Wang Y
Clin Imaging; 2024 Apr; 108():110100. PubMed ID: 38341881
[TBL] [Abstract][Full Text] [Related]
19. [
Lu Y; Li M; Massicano AVF; Song PN; Mansur A; Heinzman KA; Larimer BM; Lapi SE; Sorace AG
Molecules; 2021 Mar; 26(6):. PubMed ID: 33809310
[TBL] [Abstract][Full Text] [Related]
20.
Diwanji D; Onishi N; Hathi DK; Lawhn-Heath C; Kornak J; Li W; Guo R; Molina-Vega J; Seo Y; Flavell RR; Heditsian D; Brain S; Esserman LJ; Joe BN; Hylton NM; Jones EF; Ray KM
Radiol Imaging Cancer; 2024 Mar; 6(2):e230082. PubMed ID: 38551406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
